Ref. PREP2025-004342-\"REMEDY-7\". CALL FOR THE RECRUITMENT OF A PREDOCTORAL RESEARCHER IN TRAINING AT THE IMDEA NUTRITION FOUNDATION, FUNDED BY GRANT PREP2025-4342

Contract type: Full-time temporary employment contract for Predoctoral Research Staff in Training (Article 21 of the Spanish Science Act) – Model 404.

Organisation/Company IMDEA Food Institute Research Field Chemistry » Biochemistry Technology » Biotechnology Biological sciences » Biology Pharmacological sciences » Pharmacy Neurosciences » Other Researcher Profile First Stage Researcher (R1) Positions Master Positions Application Deadline 12 Nov 2026
- 23:59 (Europe/Madrid) Country Spain Type of Contract Other Type of Contract Extra Information Contract type: Full-time temporary employment contract for Predoctoral Research Staff in Training (Article 21 of the Spanish Science Act) – Model 404. Job Status Full-time Hours Per Week 37,5 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

Offer Description

IMDEA Nutrition is part of the Network of Madrid Institutes for Advanced Studies, promoted by the Community of Madrid with the aim of conducting research that is useful to society and of international scientific excellence. Within this framework, IMDEA Nutrition is a beneficiary of grant Ref. PID OB-I00 under the 2025 advance-processing call for grants for “Knowledge Generation Projects” and actions for the training of predoctoral research staff associated with such projects, within the framework of the State Programme to Promote Scientific and Technical Research and Knowledge Transfer, under the State Plan for Scientific, Technical and Innovation Research 2024–2027, for the implementation of the research project REMEDY-7 — “Deciphering the Role of miR-7 in Metabolic Remodelling and Cellular Dynamics in Brain Pathologies” (Ref. PID OB-I00), which includes grant PREP for the training of predoctoral research staff.

The predoctoral researcher’s activities will be carried out within the framework of the REMEDY-7 project (Ref. PID OB-I00), with the aim of completing a doctoral thesis.

To carry out research, development, knowledge transfer and innovation activities within the framework of the REMEDY-7 project, which aims to decipher the role of miR-7 in metabolic remodeling and cellular dynamics in brain pathologies.

The successful candidate will participate in the REMEDY-7 project by conducting in vitro and in vivo studies to characterize the molecular mechanisms through which miR-7 modulates cellular metabolism and the dynamics of the tumor microenvironment in glioblastoma multiforme (GBM), as well as to evaluate its therapeutic potential. Responsibilities will include investigating miR-7 expression and function, characterizing metabolic alterations and cellular processes involved in tumor progression, and evaluating its potential as a therapeutic strategy, both as a monotherapy and in combination with conventional anticancer treatments. To this end, the candidate will employ molecular and cellular biology techniques, in vitro and in vivo experimental models, gene expression analyses, functional assays, and bioinformatics and statistical analysis tools to gain further insight into the post-transcriptional and epigenetic regulatory mechanisms underlying GBM biology and identify novel RNA-based therapeutic opportunities. The successful candidate will participate in the REMEDY-7 project by conducting in vitro and in vivo studies to characterize the molecular mechanisms through which miR-7 modulates cellular metabolism and the dynamics of the tumor microenvironment in glioblastoma multiforme (GBM), as well as to evaluate its therapeutic potential. Responsibilities will include investigating miR-7 expression and function, characterizing metabolic alterations and cellular processes involved in tumor progression, and evaluating its potential as a therapeutic strategy, both as a monotherapy and in combination with conventional anticancer treatments. To this end, the candidate will employ molecular and cellular biology techniques, in vitro and in vivo experimental models, gene expression analyses, functional assays, and bioinformatics and statistical analysis tools to gain further insight into the post-transcriptional and epigenetic regulatory mechanisms underlying GBM biology and identify novel RNA-based therapeutic opportunities.

Subcriterion 1.a): Scientific and technical contributions (up to 45 points).

- The candidate’s academic record and other curricular merits will be assessed, as well as their suitability for the tasks to be performed, taking into account their academic background and professional experience.

-Participation in scientific activities relevant to the field (seminars, symposia, training courses, etc.)

-Authorship of scientific publications indexed in international databases

-Authorship of contributions to scientific conferences

-Participation in research projects

Sub-criterion 1.b)